Last reviewed · How we verify

NCT03994991

Transcranial Magnetic Stimulation (TMS) for Thoracic Surgery

Withdrawn NA Last updated 24 May 2021
What this trial tests

NA trial testing active TMS in Thoracic Surgery. Withdrawn.

Timeline
1 February 2021
Primary endpoint
19 May 2021
19 May 2021

Quick facts

Lead sponsorEmine Bayman
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date1 February 2021
Primary completion19 May 2021
Estimated completion19 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Emine Bayman

Who can join

Adults 18 to 80, any sex, with Thoracic Surgery or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with high severity of post-surgical pain scores will be randomized to transcranial magnetic stimulation (TMS) vs sham TMS groups. Both group of patients will have 10 TMS sessions during 5 days. Our hypothesis is that, the reduction in the severity of pain scores will be greater among those patients who are randomized to active TMS group compared to sham TMS group. The investigators will explore how improvements in pain correlate with changes in brain network connectivity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of active TMS

Trials testing the same drug.

Other recruiting trials for Thoracic Surgery

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03994991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing